Efficacy and Safety of Long-Acting β-Agonist/Long-Acting Muscarinic Antagonist Combinations Compare to Long-Acting β-Agonist/Inhaled Corticosteroid Combinations: A Network Meta-Analysis

被引：0
|
作者：
Ahmed, T. Said [1 ]
Al-Sarie, M. [2 ]
Srour, K. [2 ]
Rygielski, S. [3 ]
Ye, F. [2 ]
Hernandez, D. [4 ]
机构：
[1] Univ Toledo, Crit Care Pulm, 2801 W Bancroft St, Toledo, OH 43606 USA
[2] Univ Toledo, Internal Med, 2801 W Bancroft St, Toledo, OH 43606 USA
[3] Univ Toledo, Anesthesia, 2801 W Bancroft St, Toledo, OH 43606 USA
[4] Univ Toledo, Med Ctr, Pulm Crit Care Sleep Med, 2801 W Bancroft St, Toledo, OH 43606 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3045
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis
    Oba, Yuji
    Sarva, Siva T.
    Dias, Sofia
    THORAX, 2016, 71 (01) : 15 - 25
  • [2] A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
    Sion K.Y.J.
    Huisman E.L.
    Punekar Y.S.
    Naya I.
    Ismaila A.S.
    Pulmonary Therapy, 2017, 3 (2) : 297 - 316
  • [3] Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
    Oba, Yuji
    Chandran, Arul V.
    Devasahayam, Joe V.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (06) : 677 - 685
  • [4] Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for COPD: A systematic review and meta-analysis
    Horita, Nobuyuki
    Miyazawa, Naoki
    Tomaru, Koji
    Inoue, Miyo
    Kaneko, Takeshi
    RESPIROLOGY, 2015, 20 (08) : 1153 - 1159
  • [5] Comparative effectiveness and safety of inhaled corticosteroid plus long-acting β2-agonist fixed-dose combinations vs. long-acting muscarinic antagonist in bronchiectasis
    Su, Vincent Yi-Fong
    Ding, Ting-Lin
    Chang, Yuh-Lih
    Chou, Yueh-Ching
    Hwang, Hsuen-En
    Chou, Chian-Ying
    Hsu, Chia-Chen
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, : 157 - 164
  • [6] Switching from long-acting beta-agonist and inhaled corticosteroid to long-acting beta-agonist and long-acting muscarinic antagonist for chronic obstructive pulmonary disease: a case report of inhaled corticosteroid withdrawal
    Lam, Jamie Chung Mei
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 15 - 18
  • [7] Review of inhaled corticosteroid/long-acting beta2-agonist combinations
    Roefaro, John
    Daryanani, Anita A.
    FORMULARY, 2008, 43 (06) : 204 - +
  • [8] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Eung Gu Lee
    Youlim Kim
    Yong Il Hwang
    Kwang Ha Yoo
    So Eun Lee
    Kyung Yoon Jung
    Doik Lee
    Yong Bum Park
    Chin Kook Rhee
    Scientific Reports, 13
  • [9] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Lee, Eung Gu
    Kim, Youlim
    Hwang, Yong Il
    Yoo, Kwang Ha
    Lee, So Eun
    Jung, Kyung Yoon
    Lee, Doik
    Park, Yong Bum
    Rhee, Chin Kook
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis
    Oba, Yuji
    Lone, Nazir A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 469 - 479
12345